[go: up one dir, main page]

FI65252C - Foerfarande foer framstaellning av antibakteriellt och som beta-laktamasinhibitorer verksamma etrar av klavulansyra - Google Patents

Foerfarande foer framstaellning av antibakteriellt och som beta-laktamasinhibitorer verksamma etrar av klavulansyra Download PDF

Info

Publication number
FI65252C
FI65252C FI771146A FI771146A FI65252C FI 65252 C FI65252 C FI 65252C FI 771146 A FI771146 A FI 771146A FI 771146 A FI771146 A FI 771146A FI 65252 C FI65252 C FI 65252C
Authority
FI
Finland
Prior art keywords
formula
clavulanate
benzyl
ethyl
salt
Prior art date
Application number
FI771146A
Other languages
English (en)
Finnish (fi)
Other versions
FI65252B (fi
FI771146A (fi
Inventor
Thomas Trefor Howarth
Kong Luk
Roger John Ponsford
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB10082/77A external-priority patent/GB1582864A/en
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of FI771146A publication Critical patent/FI771146A/fi
Application granted granted Critical
Publication of FI65252B publication Critical patent/FI65252B/fi
Publication of FI65252C publication Critical patent/FI65252C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI771146A 1977-03-10 1977-04-12 Foerfarande foer framstaellning av antibakteriellt och som beta-laktamasinhibitorer verksamma etrar av klavulansyra FI65252C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB10082/77A GB1582864A (en) 1977-03-10 1977-03-10 Chemical process for the preparation of clavulanic acid derivatives
GB1011677 1977-03-10
GB1011677 1977-03-10
GB1008277 1977-03-10

Publications (3)

Publication Number Publication Date
FI771146A FI771146A (fi) 1978-09-11
FI65252B FI65252B (fi) 1983-12-30
FI65252C true FI65252C (fi) 1984-04-10

Family

ID=26247246

Family Applications (1)

Application Number Title Priority Date Filing Date
FI771146A FI65252C (fi) 1977-03-10 1977-04-12 Foerfarande foer framstaellning av antibakteriellt och som beta-laktamasinhibitorer verksamma etrar av klavulansyra

Country Status (19)

Country Link
JP (1) JPS53112894A (de)
AR (1) AR216505A1 (de)
AT (1) AT359188B (de)
AU (1) AU519232B2 (de)
CH (1) CH632760A5 (de)
DE (1) DE2808116A1 (de)
DK (1) DK139377A (de)
ES (1) ES467513A1 (de)
FI (1) FI65252C (de)
FR (1) FR2383184A1 (de)
GR (1) GR64160B (de)
HK (1) HK15084A (de)
IE (1) IE46478B1 (de)
IL (1) IL54078A0 (de)
KE (1) KE3337A (de)
MX (1) MX4864E (de)
NL (1) NL7802596A (de)
NO (1) NO771106L (de)
SE (1) SE442748B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862254D1 (en) * 1977-12-02 1983-06-16 Beecham Group Plc A process for the preparation of ether derivatives of clavulanic acid
JPS58187371A (ja) * 1982-04-27 1983-11-01 Nec Corp 印字濃度制御回路
DE3725375A1 (de) * 1987-07-31 1989-02-09 Bayer Ag Stabile oxapenem-3-carbonsaeuren

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1573503A (en) * 1975-12-17 1980-08-28 Glaxo Lab Ltd Clavulanic acid derivatives

Also Published As

Publication number Publication date
AT359188B (de) 1980-10-27
NO771106L (no) 1978-09-12
ES467513A1 (es) 1979-08-01
KE3337A (en) 1983-11-25
CH632760A5 (en) 1982-10-29
IL54078A0 (en) 1978-04-30
IE46478B1 (en) 1983-06-29
ATA145178A (de) 1980-03-15
AR216505A1 (es) 1979-12-28
FR2383184A1 (fr) 1978-10-06
AU519232B2 (en) 1981-11-19
JPS53112894A (en) 1978-10-02
NL7802596A (nl) 1978-09-12
HK15084A (en) 1984-02-24
SE442748B (sv) 1986-01-27
FI65252B (fi) 1983-12-30
DK139377A (da) 1978-09-11
AU3384078A (en) 1979-09-06
FI771146A (fi) 1978-09-11
MX4864E (es) 1982-11-10
GR64160B (en) 1980-02-05
FR2383184B1 (de) 1980-08-29
SE7704085L (sv) 1978-09-11
DE2808116A1 (de) 1978-09-21
IE780477L (en) 1978-09-10

Similar Documents

Publication Publication Date Title
EP0005889B1 (de) Verfahren zur Herstellung von Beta-Lactam-Derivaten, die so erhaltenen neuen Derivate sowie diese Derivate enthaltende pharmazeutische Zusammensetzungen
US4177346A (en) 1,5-Disubstituted-2-pyrrolidones
SU651704A3 (ru) Способ получени производных дибензоциклогептена, рацемических или оптически активных, или их солей
FI65252C (fi) Foerfarande foer framstaellning av antibakteriellt och som beta-laktamasinhibitorer verksamma etrar av klavulansyra
WO1996011197A1 (de) HALOGENIERTE β-CARBOLIN-DERIVATE, VERFAHREN ZU IHRER HERSTELLUNG UND VERWENDUNG DIESER SUBSTANZEN ZUR HEMMUNG DER ATMUNGSKETTE
GB2101986A (en) Thiazolinoazetidinone derivatives
DE10216967A1 (de) Verfahren zur Herstellung spezieller aromatischer Aldehyde
FR2496666A1 (fr) Nouveaux derives de cephalosporine et composition pharmaceutique les contenant
FI71562C (fi) Foerfarande foer framstaellning av 6- - substituerade penicillansyraderivat och saosom mellanprodukter anvaendbara 6-perfluoralkylsulfonyloxipenicillansyraderivat.
HU182227B (en) Process for preparing hexitols containing free carboxyl group
US5053510A (en) Process for the preparation of polycyclic compounds
US4590290A (en) Process for the preparation of 6-methoxy-1-naphthoic acid, methyl esters
GB2042511A (en) -lactone derivatives of 2-hydroxy-cyclopentane-carboxylic acid
DD216024A5 (de) Verfahren zur herstellung von halogenmethyl-6-subst.-penicillanoyloxymethyl-carbonaten
FI65251B (fi) Foerfarande foer framstaellning av antibakteriellt och som beta-laktamasinhibitorer verksamma etrar av klavulansyra
US4148995A (en) Process for preparing cephem lactones for cephalosporin-type antibiotics
SU608477A3 (ru) Способ получени производных 3-карбамоилоксиметилцефалоспорина
JPS6322585A (ja) ６−トリフルオロメチル−１ｈ−ベンゾトリアゾ−１−イル−ジフェニルホスフェイト及びセファロスポリン誘導体の製造方法
EP0120094B1 (de) Azetidinon-verbindungen
RU2005717C1 (ru) Способ получения производных аралкиламинов или их кислотно-аддитивных солей
CA1152999A (en) Process for the preparation of derivatives of clavulanic acid
US3681370A (en) Certain acyloxy thiazolidines and process for their manufacture
US3715347A (en) Process for acetylation
CS7492A3 (en) Substituted alkenoic acid and derivatives thereof, process for preparingsaid compounds and their use
CA1047510A (en) Benzopyrans

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BEECHAM GROUP LTD